Concepedia

Iris Gorfinkel

IG

Statistics

Publications

12

Citations

2K

H-Index

11

Active since

2011

Affiliations

Dalhousie University(Current)

GlaxoSmithKline (Belgium)

The University of Sydney

Westmead Institute for Medical Research

GlaxoSmithKline (United States)

Iris Gorfinkel is an author at Dalhousie University specializing in vaccination, veterinary medicine, and infectious diseases.

ORCID

Publications per year

2011–2024

12

Publications

12

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Anthony L. Cunningham, Himal Lal, Martina Kovac et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

, , +17

Efficacy Results of a Trial of a Herpes Simplex Vaccine

Robert B. Belshe, Peter A. Leone, David I. Bernstein et al. · New England Journal of Medicine · 2012 · 510 citations · Full text

, , +13

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Ana Strezova, Javier Díez‐Domingo, Kamal Al Shawafi et al. · Open Forum Infectious Diseases · 2022 · 101 citations · Full text

, , +17

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Céline Boutry, Andrew Hastie, Javier Díez‐Domingo et al. · Clinical Infectious Diseases · 2021 · 93 citations · Full text

, , +17

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois et al. · Vaccine · 2019 · 65 citations · Full text

, , +17

1–5 of 12